Middle East > Israel > Beny Steinmetz tries again for Scorpio debt arrangement

Israel: Beny Steinmetz tries again for Scorpio debt arrangement

2016/01/10

Two months next the bondholders in failing real estate company Scorpio Real Estate Ltd. (TASE: SCRP.B1) rejected a deficit arrangement proposed by billionaire Beny Steinmetz, Scorpio's controlling shareholder, Scorpio is making an extra proposition. The company today published principles for a possible new deficit arrangement that it hopes the bondholders will approve.

Like the previous proposition, the new proposition as well includes a one third reduction in the deficit, from NIS 240 million to NIS 160 million. The difference between the proposals is that under the current proposition, the remaining bond principal will be repaid in four gradually increasing payments, inclunding a minimum payment of NIS 20 million by June 30, 2016, rising to an NIS 80 million minimum payment by June 30, 2019, at the same time as it as well undertakes to repay the remaining principal to the bondholders. Under the previous proposition, payments would not have begun until June 30, 2019.

As far as is known, one of the reasons that the previous proposition did not succeed was that the some of the bondholding institutions, headed by Clal Insurance Enterprises Holdings Ltd. (TASE: CLIS), demanded an enforceable personal guarantee as a condition for its approval. Scorpio is presently claiming that Steinmetz will guarantee the payments, with the company providing the bondholders' trustee with confirmation from a lawyer that the foreign companies in which Steinmetz was "a beneficiary or one of the beneficiaries (even though he is not involved in their management, does not control them, has no influence over them, and it is by no means clear that that he received money from them)… have a surplus of assets over liabilities" better than the all to be repaid. Scorpio added, "The parent company and the controlling shareholder in the company shall not be entitled to repayment in respect of the company's debts to them as long as the reduced bond deficit has not been fully repaid."

Scorpio has been in a difficult national for completely some time, and the further decline in its situation, which led to the current deficit arrangement proposition, came in 2014, following the tension between Russia and Ukraine, which disrupted the company's business in these nations. As a result, the group's financial statements have carried a going concern warning for a considerable time. The company's initial deficit arrangement, amounting to NIS 570 million, came in 2011, with Steinmetz injecting $100 million into the company in exchange for rescheduling of the deficit.

Related Articles
  • Taking Israel's Economy Global

    2016/05/16 Israel “Izzy” Tapoohi’s five-year term leading the Development Corporation for Israel – better known as Israel Bonds – has been unquestionably consequential. In that time period, the broker-dealer has gone from underwriting and selling $600 million worth of Israeli government bonds in the US annually to yearly domestic sales exceeding $1 billion. The 65-year-old organization has been transformed from a specialty investment vehicle primarily for supporters of Israel into a significant option for investors looking to balance and diversify their portfolios. With six months left before he steps down and turns the reins of Israel Bonds over to Israel Maimon, a former cabinet secretary, Tapoohi talked to What has changed over the course of his term, the accomplishments he is proudest of, and why he thinks Israel’s economy is still a great bet.
  • Teva set to win EU okay for $40.5-billion Allergan deal

    2016/04/16 Teva Pharmaceutical Industries is expected to win EU antitrust approval for its $40.5-billion (U.S.) (£24.4-billion) bid for Allergan’s generics unit next agreeing to sell off some of its products to appease regulators, three people familiar with the matter said on Wednesday. Teva, the world’s biggest generic drugsmaker, will divest some drugs by presently on the market and others in the pipeline to address competition concerns by the European Commission, the people said. The package includes products from both Teva and Allergan.
  • Streaming Giant Netflix Comes to Israel

    2016/02/14 The online streaming website Netflix announced on Wednesday that it was expanding its availability to 130 additional nations, inclunding Israel, causing millions in the country to rejoice as the long-awaited service finally arrived. Before available in only 60 nations worldwide, Netflix, the world’s leading streaming site with 70 million subscribers, was launched in the US in 2007 and expanded to Canada, Latin America, Europe, Australia, New Zealand and Japan, leaving most of the world without access.
  • NASDAQ Teams Up with Tel Aviv Stock Exchange to Nurture Israeli Start-Ups

    2016/02/13 The Tel Aviv Stock Exchange (TASE) and NASDAQ, the world’s second-major stock exchange, announced a joint venture on Tuesday to build a private market for Israeli startup companies before they go public. The venture, which will be based in Tel Aviv, will be run by management selected by both exchanges. It will provide Israeli startups with strategic counseling and mentoring, exclusive networking, and a private, secondary market for financing, in an effort to help small Israeli companies get the support they need to face the challenges of building a business in Israel’s difficult market.
  • Experts Downplay Israeli Mission Closings, Say U.S.-Israel Bonds Not Affected

    2016/02/13 Israel’s Foreign Ministry on Wednesday announced the next closure of five diplomatic missions abroad due to budgetary considerations. Despite the Israeli consulate in Philadelphia’s presence part the closures, public policy experts say the development will not adversely affect U.S.-Israel relations. “In the last decade a lot of nations, inclunding the United States, have closed consulates. It’s at no time a good thing, but we should not exaggerate the impact. This will have no impact on U.S.-Israel diplomatic or political relations,” Elliott Abrams, a senior fellow for Middle Eastern Studies at the Council on Foreign Relations think tank inclunding a former official in the George W. Bush and Ronald Reagan presidential administrations,